Hyundai Motor Co. is shifting gears, converting a sedan production line to accommodate the surging global SUV demand. This strategic move, decided in a recent Employment Security Committee meeting, targets the popular North American Palisade and Tucson models.
The move comes as a response to the current market dynamics, where the popularity of SUVs has surged globally, resulting in high demand for SUV production lines. Concurrently, production lines for passenger cars have experienced reduced volumes, along with concerns about job security.
Under the new production timeline, North American Palisade production is set to commence on Line 1 at Ulsan Plant 5, starting in March next year. Furthermore, the production of the Tucson model will be ramped up in the second half of next year at Ulsan Plant 3.
Dedicated production lines will receive Palisade volumes from Line 1 at Ulsan Plant 4 and Tucson volumes from Line 2 at Ulsan Plant 5. These measures aim to address the backlog of SUV orders in North America and meet the increased demand for SUVs.
Earlier, Hyundai Motor North America had explored establishing a new plant in Canada due to the overwhelming demand for SUVs. However, the labor union actively advocated for work-sharing arrangements across domestic plants to safeguard domestic jobs rather than establishing new overseas plants.
To proceed with coordinating production across various domestic facilities, the consent of the union’s members is required. The union remains optimistic about the growth trajectory of Palisade sales, expecting an increase from 225,000 units in 2025 to 252,000 units in 2026. Similarly, Tucson sales are projected to rise from 290,000 units to 313,000 units during the same period.
As Hyundai Motor Co. prepares to ramp up production, it aims to meet the growing overseas demand for its popular SUV models, Tucson and Palisade. Officials from the automaker anticipate an annual shortfall of approximately 100,000 units for both models in the medium to long term.
Photo: Duncan Winslow/Unsplash


Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Japan Eyes Bigger GPIF Investment in Domestic Assets as BOJ Independence Concerns Grow
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Cuba Power Outage Sparks Havana Protests as Fuel Crisis Deepens
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
Google promotes ‘teacher approved’ apps for kids. Here’s what parents should know
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany
Oil Prices Rise as U.S.-Iran Conflict Fuels Strait of Hormuz Supply Fears
Yes, government influences wages – but not just in the way you might think
Bernstein Raises 2026 Nickel Price Forecast as Indonesia Tightens Supply
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Dollar Slips as Oil Prices Ease, Fed Rate Outlook Remains Uncertain
What’s the difference between baking powder and baking soda? It’s subtle, but significant 



